|
|
Post by mango on May 24, 2017 14:57:55 GMT -5
Substituted diketopiperazine analogs for use as drug delivery agentsType: Grant Filed: November 18, 2015 Date of Patent: May 23, 2017 Assignee: MannKind Corporation Inventor: Kelly Sullivan Kraft patents.justia.com/patent/9655850
|
|
|
|
Post by cedafuntennis on May 24, 2017 16:09:54 GMT -5
Nice but MNKD has enough patents already to fill one of those helicopter warehouses left empty on the Tustin Air Force base. We need to monetize some of those patents and do it yesterday to put the market worries of bankruptcy to rest. That will lift the PPS and then make running this company so much easier.
|
|
|
|
Post by babaoriley on May 24, 2017 16:15:21 GMT -5
We need more patients, not patents.
|
|
|
|
Post by compound26 on May 24, 2017 16:21:11 GMT -5
We need more patients, not patents. Mannkind proposes to exchange each patent for one patient.  However, they were told that they should be more patient and patients will come. |
|
|
|
Post by slugworth008 on May 24, 2017 16:23:48 GMT -5
We need more patients, not patents. Bingo, bango, bongo!!! Screw the patents - IDK no help to the PPS |
|
|
|
Post by slugworth008 on May 24, 2017 16:24:25 GMT -5
Substituted diketopiperazine analogs for use as drug delivery agentsType: Grant Filed: November 18, 2015 Date of Patent: May 23, 2017 Assignee: MannKind Corporation Inventor: Kelly Sullivan Kraft patents.justia.com/patent/9655850 So what - IDK - where's the PPS?  Oh yeah, nothing like a 5 for 1 rs to make one giddy. |
|
|
|
Post by robbmo on May 24, 2017 16:39:44 GMT -5
Substituted diketopiperazine analogs for use as drug delivery agentsType: Grant Filed: November 18, 2015 Date of Patent: May 23, 2017 Assignee: MannKind Corporation Inventor: Kelly Sullivan Kraft patents.justia.com/patent/9655850 I'm not a chemist, but if I am reading this one correctly, it could have potential to be able to adsorb larger particle sizes. That is one of the limitations of the the current FDKP molecule... |
|
|
|
Post by mnholdem on May 24, 2017 16:50:24 GMT -5
We need more patients, not patents. Bingo, bango, bongo!!! Screw the patents - IDK no help to the PPS With all due respect, some posters may have a much longer view of the company's technology.  |
|
|
|
Post by seanismorris on May 24, 2017 17:27:06 GMT -5
Patents are worth mentioning...
I thought half the value of MannKind was in it's patents... that was when MNKD was worth 2B.
I thought extending patent protection was important for Afrezza, and new patents (like this one) would result in Afrezza 2.0.
Then Afrezza came to market and sold poorly, and partners eager to license TS didn't show up as I expected.
Fast forward to today, if there isn't a path forward to monitize a MannKind patent it's worthless.
Only If Afrezza is successful do they become worth something.
It's all, and only, about scripts.
|
|
|
|
Post by mytakeonit on May 24, 2017 17:45:52 GMT -5
We need more patients, not patents. We need the patents ... to get more patients ... just have more patience. Ahhh ... what were we talking about? |
|
|
|
Post by babaoriley on May 24, 2017 18:56:42 GMT -5
Bingo, bango, bongo!!! Screw the patents - IDK no help to the PPS With all due respect, some posters may have a much longer view of the company's technology. Sorry to disagree, mn, but patents are overrated. They are a MUST, of course, and that's a given - I mean any biotech or tech patents as much as possible. But more often than not, most of them don't truly add to value. I've seen so many companies that had so many patents and made so many investors so happy. Then they see other companies doing similar things and they ask, "why are we not stopping them?" Either they can't, or they don't want to spend the money, of if they do, the other company has been careful enough to avoid technically infringing. Once in a while, sure, you score with one, but compare to how many are handed out? |
|
|
|
Post by mnholdem on May 24, 2017 19:31:39 GMT -5
It's true, baba, that patents don't necessarily add value, until they become marketable. I don't recall saying anything about $value of patents or their impact on share price. But I for one like to be kept informed and apprised of patents because a company that doesn't invest in the future doesn't have one, IMHO.
Shareholders who aren't interested in the R&D department can simply flip to the next thread without belittling or poking fun at us who are interested, right?
:-)
|
|
|
|
Post by lennymnkd on May 24, 2017 19:59:20 GMT -5
I for one are interested in the patents !
|
|
|
|
Post by brotherm1 on May 24, 2017 20:13:27 GMT -5
Bingo, bango, bongo!!! Screw the patents - IDK no help to the PPS With all due respect, some posters may have a much longer view of the company's technology. Well said and (edit: perhaps) from the most intelligent man on this board. |
|
|
|
Post by babaoriley on May 25, 2017 0:33:55 GMT -5
With all due respect, some posters may have a much longer view of the company's technology. Well said and (edit: perhaps) from the most intelligent man on this board. Brotherm1, thank goodness you didn't say "person," Sports would have been livid! |
|
However, they were told that they should be more patient and patients will come. 
Oh yeah, nothing like a 5 for 1 rs to make one giddy.
